These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 25243648

  • 1. Survival benefit of repeat liver transplantation in the United States: a serial MELD analysis by hepatitis C status and donor risk index.
    Biggins SW, Gralla J, Dodge JL, Bambha KM, Tong S, Barón AE, Inadomi J, Terrault N, Rosen HR.
    Am J Transplant; 2014 Nov; 14(11):2588-94. PubMed ID: 25243648
    [Abstract] [Full Text] [Related]

  • 2. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
    Hung K, Gralla J, Dodge JL, Bambha KM, Dirchwolf M, Rosen HR, Biggins SW.
    Liver Transpl; 2015 Nov; 21(11):1365-73. PubMed ID: 25865434
    [Abstract] [Full Text] [Related]

  • 3. Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence.
    Song AT, Sobesky R, Vinaixa C, Dumortier J, Radenne S, Durand F, Calmus Y, Rousseau G, Latournerie M, Feray C, Delvart V, Roche B, Haim-Boukobza S, Roque-Afonso AM, Castaing D, Abdala E, D'Albuquerque LA, Duclos-Vallée JC, Berenguer M, Samuel D.
    World J Gastroenterol; 2016 May 14; 22(18):4547-58. PubMed ID: 27182164
    [Abstract] [Full Text] [Related]

  • 4. Liver Retransplantation Associated With Kidney Transplantation for End-stage Liver Graft Disease and Renal Insufficiency: A Morbid Procedure on a Unique Subgroup of Patients.
    Cauchy F, Vibert E, Cherqui D, Perdigao F, Sepulveda A, Samuel D, Calmus Y, Conti F, Adam R, Soubrane O, Scatton O.
    Transplantation; 2020 Jul 14; 104(7):1403-1412. PubMed ID: 31651789
    [Abstract] [Full Text] [Related]

  • 5. The Evolution of Redo Liver Transplantation Over 35 Years: Analysis of 654 Consecutive Adult Liver Retransplants at a Single Center.
    Kaldas FM, Horwitz JK, Noguchi D, Korayem IM, Markovic D, Ebaid S, Agopian VG, Yersiz H, Saab S, Han SB, El Kabany MM, Choi G, Shetty A, Singh J, Wray C, Barjaktarvic I, Farmer DG, Busuttil RW.
    Ann Surg; 2023 Sep 01; 278(3):441-451. PubMed ID: 37389564
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients.
    Avolio AW, Cillo U, Salizzoni M, De Carlis L, Colledan M, Gerunda GE, Mazzaferro V, Tisone G, Romagnoli R, Caccamo L, Rossi M, Vitale A, Cucchetti A, Lupo L, Gruttadauria S, Nicolotti N, Burra P, Gasbarrini A, Agnes S, Donor-to-Recipient Italian Liver Transplant (D2R-ILTx) Study Group.
    Am J Transplant; 2011 Dec 01; 11(12):2724-36. PubMed ID: 21920017
    [Abstract] [Full Text] [Related]

  • 8. Optimal timing of hepatitis C treatment for patients on the liver transplant waiting list.
    Chhatwal J, Samur S, Kues B, Ayer T, Roberts MS, Kanwal F, Hur C, Donnell DM, Chung RT.
    Hepatology; 2017 Mar 01; 65(3):777-788. PubMed ID: 27906468
    [Abstract] [Full Text] [Related]

  • 9. How can we utilize livers from advanced aged donors for liver transplantation for hepatitis C?
    Uemura T, Nikkel LE, Hollenbeak CS, Ramprasad V, Schaefer E, Kadry Z.
    Transpl Int; 2012 Jun 01; 25(6):671-9. PubMed ID: 22487509
    [Abstract] [Full Text] [Related]

  • 10. Impact of the donor risk index on the outcome of hepatitis C virus-positive liver transplant recipients.
    Maluf DG, Edwards EB, Stravitz RT, Kauffman HM.
    Liver Transpl; 2009 Jun 01; 15(6):592-9. PubMed ID: 19479802
    [Abstract] [Full Text] [Related]

  • 11. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.
    Nadim MK, DiNorcia J, Ji L, Groshen S, Levitsky J, Sung RS, Kim WR, Andreoni K, Mulligan D, Genyk YS.
    J Hepatol; 2017 Sep 01; 67(3):517-525. PubMed ID: 28483678
    [Abstract] [Full Text] [Related]

  • 12. The corrected donor age for hepatitis C virus-infected liver transplant recipients.
    Dirchwolf M, Dodge JL, Gralla J, Bambha KM, Nydam T, Hung KW, Rosen HR, Feng S, Terrault NA, Biggins SW.
    Liver Transpl; 2015 Aug 01; 21(8):1022-30. PubMed ID: 26074140
    [Abstract] [Full Text] [Related]

  • 13. End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients.
    Ahn J, Bhuket T, Mosadeghi S, Frenette C, Liu B, Wong RJ.
    Hepatol Int; 2016 Sep 01; 10(5):838-46. PubMed ID: 27221700
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry.
    Taniguchi M.
    Clin Transpl; 2012 Sep 01; ():41-65. PubMed ID: 23721009
    [Abstract] [Full Text] [Related]

  • 16. Donor risk factors in orthotopic liver transplant: analysis of the OPTN/UNOS registry.
    Kawakita S, Everly MJ.
    Clin Transpl; 2013 Sep 01; ():13-22. PubMed ID: 25095488
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Liver transplant recipients and prioritization of anti-HCV therapy: an Italian cohort analysis.
    Lanini S, Nanni Costa A, Grossi PA, Procaccio F, Ricci A, Capobianchi MR, Terrault NA, Ippolito G.
    Liver Int; 2016 Mar 01; 36(3):410-7. PubMed ID: 26264452
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.